申请人:Kalyra Pharmaceuticals, Inc.
公开号:US20180207132A1
公开(公告)日:2018-07-26
Disclosed herein are spirocyclic compounds, together with pharmaceutical compositions and methods of ameliorating and/or treating a cancer described herein with one or more of the compounds described herein.